XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153 | +131.8% | 4,493 | +165.4% | 0.00% | – |
| Q2 2023 | $66 | -23.3% | 1,693 | -29.2% | 0.00% | – |
| Q1 2023 | $86 | -9.5% | 2,392 | 0.0% | 0.00% | – |
| Q4 2022 | $95 | -99.9% | 2,392 | 0.0% | 0.00% | – |
| Q3 2022 | $86,000 | +53.6% | 2,392 | +28.8% | 0.00% | – |
| Q2 2022 | $56,000 | -6.7% | 1,857 | 0.0% | 0.00% | – |
| Q1 2022 | $60,000 | +3.4% | 1,857 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | +241.2% | 1,857 | +68.2% | 0.00% | – |
| Q3 2021 | $17,000 | -19.0% | 1,104 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -51.2% | 1,104 | -54.3% | 0.00% | – |
| Q1 2021 | $43,000 | +16.2% | 2,417 | 0.0% | 0.00% | – |
| Q4 2020 | $37,000 | +37.0% | 2,417 | 0.0% | 0.00% | – |
| Q3 2020 | $27,000 | -10.0% | 2,417 | 0.0% | 0.00% | – |
| Q2 2020 | $30,000 | – | 2,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |